Correlation Between ABVC Biopharma and ACADIA Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and ACADIA Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and ACADIA Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and ACADIA Pharmaceuticals, you can compare the effects of market volatilities on ABVC Biopharma and ACADIA Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of ACADIA Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and ACADIA Pharmaceuticals.
Diversification Opportunities for ABVC Biopharma and ACADIA Pharmaceuticals
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ABVC and ACADIA is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and ACADIA Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACADIA Pharmaceuticals and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with ACADIA Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACADIA Pharmaceuticals has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and ACADIA Pharmaceuticals go up and down completely randomly.
Pair Corralation between ABVC Biopharma and ACADIA Pharmaceuticals
Given the investment horizon of 90 days ABVC Biopharma is expected to generate 6.44 times more return on investment than ACADIA Pharmaceuticals. However, ABVC Biopharma is 6.44 times more volatile than ACADIA Pharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. ACADIA Pharmaceuticals is currently generating about -0.23 per unit of risk. If you would invest 105.00 in ABVC Biopharma on January 25, 2024 and sell it today you would earn a total of 30.00 from holding ABVC Biopharma or generate 28.57% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
ABVC Biopharma vs. ACADIA Pharmaceuticals
Performance |
Timeline |
ABVC Biopharma |
ACADIA Pharmaceuticals |
ABVC Biopharma and ACADIA Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ABVC Biopharma and ACADIA Pharmaceuticals
The main advantage of trading using opposite ABVC Biopharma and ACADIA Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, ACADIA Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACADIA Pharmaceuticals will offset losses from the drop in ACADIA Pharmaceuticals' long position.ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Aileron Therapeutics |
ACADIA Pharmaceuticals vs. Madrigal Pharmaceuticals | ACADIA Pharmaceuticals vs. Viking Therapeutics | ACADIA Pharmaceuticals vs. Sarepta Therapeutics | ACADIA Pharmaceuticals vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Global Correlations Find global opportunities by holding instruments from different markets | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
CEOs Directory Screen CEOs from public companies around the world | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |